Methylenetetrahydrofolate reductase C677T and methionine synthase A2756G polymorphisms influence on leukocyte genomic DNA methylation level

Gene

Volumn 533, Issue 1, 2014, Pages 168-172

  Weiner, Alexandra S ^a,b   Boyarskikh, Uljana A ^a,c   Voronina, Elena N ^a   Mishukova, Olga V ^a   Filipenko, Maxim L ^a,c  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b NOVOSIBIRSK STATE UNIVERSITY   (Russian Federation)

^c ALTAI STATE UNIVERSITY   (Russian Federation)

Author keywords

Methionine synthase; Methylation; Methylenetetrahydrofolate reductase; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); A2756G; C677T; GENOMIC DNA; HOMOCYSTEINE; METHIONINE SYNTHASE; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; DNA METHYLATION; ENZYME POLYMORPHISM; FEMALE; GENE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; HYDROLYSIS; LEUKOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN SYNTHESIS;

BETAINE-HOMOCYSTEINE S-METHYLTRANSFERASE; BHMT; METHIONINE SYNTHASE; METHYLATION; METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR; MTR; OD; OPTICAL DENSITY; PCR; POLYMERASE CHAIN REACTION; POLYMORPHISM; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; SAH; SAM;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; BASE SEQUENCE; DNA METHYLATION; DNA PRIMERS; HUMANS; LEUKOCYTES; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC;

EID: 84887422252     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2013.09.098     Document Type: Article

References (33)

1. Amorim M.R., Lima M.A., Castilla E.E., Orioli I.M. Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C>T: a meta-analysis. Am. J. Med. Genet. A 2007, 143A:1726-1732.
2. Blom H.J., Smulders Y. Overview of homocysteine and folate metabolism. With special references to cardiovascular disease and neural tube defects. J. Inherit. Metab. Dis. 2011, 34:75-81.
3. Castro R., et al. 5,10-Methylenetetrahydrofolate reductase 677C->T and 1298A->C mutations are genetic determinants of elevated homocysteine. QJM 2003, 96:297-303.
4. Castro R., et al. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 2003, 49:1292-1296.
5. Castro R., et al. 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C->T and 1298A->C mutations are associated with DNA hypomethylation. J. Med. Genet. 2004, 41:454-458.
6. Castro R., et al. Intracellular S-adenosylhomocysteine increased levels are associated with DNA hypomethylation in HUVEC. J. Mol. Med. 2005, 83:831-836.
7. Chen L.H., Liu M., Hwang H., Chen L., Korenberg J., Shane B. Human Methionine Synthase. Biochemistry 1997, 272:3628-3634.
8. Chen J., et al. Influence of a methionine synthase (D919G) polymorphism on plasma homocysteine and folate levels and relation to risk of myocardial infarction. Atherosclerosis 2001, 154:667-672.
9. Davis C.D., Uthus E.O. DNA Methylation, Cancer Susceptibility, and Nutrient Interactions. Exp. Biol. Med. 2004, 229:988-995.
10. Fredriksen A., Meyer K., Ueland P.M., Vollset S.E., Grotmol T., Schneede J. Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism. Hum. Mutat. 2007, 28:856-865.
11. Friso S., et al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:5606-5611.
12. Harmon D.L., et al. Methionine synthase D919G polymorphism is a significant but modest determinant of circulating homocysteine concentrations. Genet. Epidemiol. 1999, 17:298-309.
13. Huang L., Song X.M., Zhu W., Li Y. Plasma homocysteine and gene polymorphisms associated with the risk of hyperlipidemia in northern Chinese subjects. Biomed. Environ. Sci. 2008, 21:514-520.
14. Jacques P.F., et al. Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study. Atherosclerosis 2003, 166:49-55.
15. James S.J., Melnyk S., Pogribna M., Pogribny I.P., Caudill M.A. Elevation in S-adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism for homocysteine-related pathology. J. Nutr. 2002, 132:2361-2366.
16. Klerk M., et al. The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study. Thromb. Res. 2003, 110:87-91.
17. Liu J.J., Ward R.L. Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer. Adv. Genet. 2010, 71:79-121.
18. Ma J., et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol. Biomarkers Prev. 1999, 8:825-829.
19. Montjean D., et al. Polymorphisms in MTHFR and MTRR genes associated with blood plasma homocysteine concentration and sperm counts. Fertil. Steril. 2011, 95:635-640.
20. Nordgren K.K., et al. Methionine adenosyltransferase 2A/2B and methylation: gene sequence variation and functional genomics. Pharmacology 2011, 39:2135-2147.
21. Paz M.F., et al. Germ-line variants in methyl-group metabolism genes and susceptibility to DNA methylation in normal tissues and human primary tumors. Cancer Res. 2002, 62:4519-4524.
22. Robertson K.D. DNA methylation and human disease. Nat. Rev. Genet. 2005, 6:597-610.
23. Rozen R. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR). Thromb. Haemost. 1997, 78:523-526.
24. Stern L.L., Mason J.B., Selhub J., Choi S.W. Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol. Biomarkers Prev. 2000, 9:849-853.
25. Tanaka T., et al. Genome-wide association study of vitamin B6, vitamin B12, folate, and homocysteine blood concentrations. Am. J. Hum. Genet. 2009, 84:477-482.
26. Tsai M.Y., Bignell M., Yang F., Welge B.G., Graham K.J., Hanson N.Q. Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels. Atherosclerosis 2000, 149:131-137.
27. Walker R.D., Duerre J.A. S-adenosylhomocysteine metabolism in various species. Can. J. Biochem. 1975, 53:312-319.
28. Wang L., et al. Relation between hypomethylation of long interspersed nucleotide elements and risk of neural tube defects. Am. J. Clin. Nutr. 2010, 91:1359-1367.
29. Weiner A.S., et al. Polymorphisms in folate-metabolizing genes and risk of non-Hodgkin's lymphoma. Leuk. Res. 2011, 35:508-515.
30. Wolffe A.P., Matzke M.A. Epigenetics: regulation through repression. Science 1999, 286:481-486.
31. Yates Z., Lucock M. Methionine synthase polymorphism A2756G is associated with susceptibility for thromboembolic events and altered B vitamin/thiol metabolism. Haematologica 2002, 87:751-756.
32. Yi P., Melnyk S., Pogribna M., Pogribny I.P., Hine R.J., James S.J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 2000, 275:29318-29323.
33. Zintzaras E., Giannouli S., Rodopoulou P., Voulgarelis M. The role of MTHFR gene in multiple myeloma. J. Hum. Genet. 2008, 53:499-507.